Tomas J. Heyman is Director of EXELIXIS, INC.. Currently has a direct ownership of 37,014 shares of EXEL, which is worth approximately $1.27 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 18,838 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37K
0% 3M change
103.64% 12M change
Total Value Held $1.27 Million

Tomas J. Heyman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Grant, award, or other acquisition
-
18,838 Added 33.73%
37,014 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
18,176 Added 50.0%
18,176 Common Stock

Also insider at

OPTN
OptiNose, Inc. Healthcare
AKRO
Akero Therapeutics, Inc. Healthcare
ADGI
Adagio Therapeutics, Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
TJH

Tomas J. Heyman

Director
Waltham, MA

Track Institutional and Insider Activities on EXEL

Follow EXELIXIS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL